Acupuncture for Paclitaxel-Induced Peripheral Neuropathy


Autor: Yu-Xue Zhao


Journal: Journal of Pain Research 2021:14 993–1005, englisch


Paclitaxel-induced peripheral neuropathy (PIPN) is a common and intractable side effect of the conventional chemotherapeutic agent paclitaxel. Acupuncture has been reported as an effective alternative therapy in treatment of PIPN in both basic studies and clinical trials. However, there is a lack of comprehensive surveys to summarize the action of acupuncture in management of PIPN. In this review, we briefly demonstrate the basic pathology of PIPN, which includes the activation of ion channels, mitochondrial dysfunction, disruption of axonal transport and also neuro-inflammatory involvement.

Meanwhile, we review both the clinical and basic studies as an emphasis to give a general overview of the therapeutic effect of acupuncture against PIPN. Finally, we summarize the current known mechanisms underlying the action of acupuncture against PIPN mainly at peripheral and spinal levels, which include various neurotransmitters, multiple receptors, different types of enzymes and molecules. In conclusion, acupuncture could be considered as a potential alternative therapy in treatment of PIPN, and further clinical and experimental studies are called for in the future.

 


Andere Benutzer haben sich neben diesem auch noch folgende Artikel angesehen:

Can Traditional Chinese Medicine Diagnosis Be Parameterized and Standardized?
Luís Carlos Matos et al; 2021

The Effectiveness of Participant Blinding of Non-Penetrating Sham/Placebo Acupuncture in Clinical Trials
Yee Hung Gan et al; 2021

Clinical efficacy and safety of Chinese herbal medicine versus placebo for the treatment of chronic obstructive pulmonary disease
ChanXiong et al; 2021




 
 

Vorheriger Artikel

Übersicht

Nächster Artikel
 

Link zum Journal